2016 | Kidney Cancer TV

2016 Kidney Cancer Association Patient & Survivor Conference

Stanford Cancer Center, Palo Alto, CA Saturday, August 20, 2016

Welcome to the 2016 Kidney Cancer Association Patient & Survivor Conference

Sandy Srinivas, MD

Overview of Kidney Cancer Association

Carrie Konosky, Co-CEO

Diagnosis and Prognostic Factors of Kidney Cancer

Sunny Kao, MD

Surgical Management

Benjamin Chung, MD

Using “Big” Data to Improve Kidney Cancer Care

John Leppert, MD, MS

The Evolving Landscape of Treatments for Kidney Cancer

Sumit Shah, MD, MPH

How Do We Know Your Treatment is Working?

Alice Fan, MD

The Genomics of Kidney Cancer

Alexey Aleshin, MD, MBA

Fear of Missing Out

Jordan Chavez, LCSW

2016 Kidney Cancer Association Patient & Survivor Conference

Fred Hutchinson Cancer Research Center Seattle, WA July 16, 2016

Welcome

Scott S. Tykodi, M.D., PhD.

Introduction to the Kidney Cancer Association

Carrie Konosky, MBA, Co-CEO

Genetics of Kidney Cancer

Fuki Marie Hisama, M.D.

Contemporary Surgical Management of Localized and Metastatic Kidney Cancer

John L. Gore, M.D., MS, FACS

New and Emerging Systemic Treatment Options for Metastatic Kidney Cancer

Scott S. Tykodi, M.D., PhD.

Updates in Radiation Therapy for Kidney Cancer

Jing Zeng, M.D.

Inflammation, Cancer and Diet

Linda Kasser, RD, CSO, CD

Assessing Kidney Function: How much do you really need?

Kimberly Muczynski, M.D., PhD.

Panel Discussion

Patient and Caregiver Perspective

Julie Chmura, Patient & Art Chmura, Caregiver

Closing Remarks

Scott S. Tykodi, M.D., PhD.

2016 National Patient, Survivor, and Caregiver Conference

M.D. Anderson Cancer Center Houston, TX April 16, 2016

Surgical Management of Locally Advanced Renal Cell Carcinoma

Christopher Wood, M.D.

Systemic Therapy for Metastatic Non-clear Cell RCC: Are There Any Good Options?

Nazir M. Tannir, MD

Targeted Therapies For The Treatment Of Kidney Cancer

Eric Jonasch, MD

Discussion Panel

Christopher Wood, MD, Surena Matin, MD, Jose Karam, MD

Who Should Have A Cytroreductive Nephrectomy and/or Metastasectomy In The Setting of Metastatic Renal Cell Carcinoma

Jose A. Karam, MD, FACS

Evaluation and Management of the Small Renal Mass

Surena F. Matin, MD